FDA clears iSchemaView imaging platform for selecting stroke patients for clot removal

Michael Walter | | Radiology Business | Medical Imaging

iSchemaView has received FDA clearance for its RAPID neuroimaging platform to be used for selecting stroke patients for endovascular thrombectomy. It is the first imaging platform to receive such approval.

Providers can now use RAPID CT-Perfusion and RAPID MR-Perfusion, two tools included in the RAPID platform, to help them find patients who would benefit the most from such a procedure.   

“This FDA clearance confirms RAPID as the de facto standard in neuroimaging, not only for the automated analysis of brain images derived from CT and MRI, but now for the diagnosis and treatment of stroke,” Don Listwin, CEO of iSchemaView, said in a prepared statement. “The new clearance will particularly benefit smaller community hospitals and the patients they serve. Because RAPID enables stroke treatment decisions that are based on intuitive and easily interpretable real-time views of brain perfusion, physicians will quickly and easily be able to determine which patients can be treated locally and which require urgent transfer to thrombectomy centers—bolstering the capabilities of smaller hospitals and therefore improving patient care.”

Back in May 2018, iSchemaView announced that its RAPID CTA solution had gained FDA clearance.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Radiologists call on AMA to push for new federal IT interoperability standards
AMA resolution backs expanded low-dose CT screenings for lung cancer, heart risk
Should more imaging be included in physicals?
Tariffs will have a significant impact on the nuclear imaging supply chain in the US
Tariffs will cost Philips Healthcare up to $340M
Enhancing STAT radiology exam order efficiency to reduce turnaround time

Around the web

Cardiovascular Business
FDA-cleared software increases throughput for flurpiridaz back-to-back rest-stress imaging

The new F-18 flurpiridaz radiotracer is expected to help drive cardiac PET growth, but it requires waiting between rest and stress scans. Software from MultiFunctional Imaging can help care teams combat that problem.

Health Imaging
MRI projectile incident likely to result in a 'seven-figure sum' repair bill for hospital

News of an incident is a stark reminder that healthcare workers and patients aren’t the only ones who need to be aware around MRI suites.

Health Imaging
American College of Radiology announces significant expansion of Lung Cancer Screening Registry

The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.